Skip to Content Skip to Content

Cancer Research

Secondary cancers following CAR T cell therapy are rare
3d illustration of a damaged and disintegrating cancer cell.

Image: iStock/vitanovski

Secondary cancers following CAR T cell therapy are rare

A new Penn Medicine analysis shows that the development of any type of second cancer is a rare occurrence, and some of the earliest patients have gone on to experience long-lasting remissions of a decade or more.

From Penn Medicine News

New AI tool brings precision pathology for cancer into quicker, sharper focus
A robot hand holding a model of DNA.

Image: iStock/iLexx

New AI tool brings precision pathology for cancer into quicker, sharper focus

Researchers at Penn Medicine have developed an artificial intelligence tool to quickly analyze gene activities in medical images and provide single-cell insight into diseases in tissues and tissue microenvironments.

Frank Otto

Penn started giving cancer patients free rides to appointments. It helped reduce no-shows and increase clinical trial enrollment

Penn started giving cancer patients free rides to appointments. It helped reduce no-shows and increase clinical trial enrollment

The Abramson Cancer Center is attempting to address one of the most common challenges cancer patients face: lack of transportation to critically important appointments. Robert Vonderheide and Carmen Guerra of the Perelman School of Medicine are quoted on the Ride Health initiative.

Godfather of mRNA vaccines reveals plans to immunize people against cancer years before tumors strike to ‘the disease from ever appearing’

Godfather of mRNA vaccines reveals plans to immunize people against cancer years before tumors strike to ‘the disease from ever appearing’

Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize for mRNA vaccines along with Katalin Karikó, is researching an mRNA vaccine against cancer.